# TrueMe reviews (2026): GLP-1 telehealth sellers | This GLP

The product page says no intake form is required before payment.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/trueme
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Pay first, intake after

# TrueMe review

The product page says no intake form is required before payment.

## The verdict

TrueMe puts a line directly under its semaglutide price that most of this category would never print: no intake form is required before you pay, with a full refund if a provider does not approve. The order of operations is the finding, and the second one is geography, because the same page names six states and nothing outside them.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

Dose pricing

Flat across doses

States

6

From

From $151/mo

Dose published

No

Prescription

Required

Compounded

Yes — not FDA-approved

Pharmacy

Not named

Availability

6 states

TrueMe sells compounded semaglutide and compounded tirzepatide by weekly injection, both prepared with added B vitamins, alongside NAD+ and sermorelin on the same four-card home page. The rate is described as covering the consultation, the medication, shipping, supplies and ongoing provider support, with the phrase no membership or hidden fees repeated across the top of the site. Coverage is the constraint rather than the price, and the company says more states are coming.

1.  ## Who writes the prescription, and what do they see?
    
    A provider decides whether treatment is appropriate, and the refund promise is what carries the weight here, since a buyer has already paid by the time that decision is made. The site does not name a provider, a medical group or a medical director, and the four-step explainer describes questions being answered rather than a clinician reading anything in particular. Ongoing provider support is listed inside the price on both product pages. What happens between payment and approval is never described.
    
    Everything runs through a patient portal, with a four-step path from choosing a treatment to receiving it, and the company publishes a free guide plus three calculators alongside the catalog. The price is stated to be all-inclusive on every card, and the product pages repeat that in capitals beneath the plan table. Cancellation is offered at any time. Shipping and injection supplies sit inside the figure rather than beside it.
    
2.  ## What happens when the dose goes up?
    
    The site advertises the same price at any dose in its scrolling banner, which means the rate a buyer starts on holds as the weekly dose climbs. Neither product page prints a milligram figure, so the ladder that rate covers is not published anywhere a buyer can check. Nothing states who approves a step up, or how long the first dose is held. The banner is the whole of the disclosure.
    
3.  ## What the price includes
    
    Each molecule has two rungs: a month-to-month figure and a three-month plan billed as one payment, with the three-month rung marked most popular and its single charge printed beside the monthly equivalent. Tirzepatide sits one tier above semaglutide on both rungs. The home page shows the same two figures per product as a small table before a buyer clicks through. Nothing longer than three months is offered.
    
4.  ## What it claims, and what it cites
    
    Both lines are compounded rather than manufactured, and TrueMe states plainly that it is neither a state-licensed pharmacy nor a drug manufacturer. The dispensing pharmacy is described as licensed and third-party but is not named. Compounded preparations are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.
    

## Where it holds up, and where it does not

-   Strength: The refund condition is printed beside the price
-   Strength: The three-month charge is shown as one payment
-   Strength: Same price at every titration dose
-   Strength: Shipping and supplies sit inside the rate
-   Strength: No membership fee is charged
-   Limitation: Payment comes before the intake form
-   Limitation: Only six states are served
-   Limitation: The dispensing pharmacy goes unnamed
-   Limitation: No prescriber or medical group is named
-   Limitation: No milligram dose appears on either page

## What the evidence says about this kind of treatment

The assessment above is about TrueMe. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A buyer in one of its six states who wants refund terms stated before the intake.

Wrong for

A buyer who expects a clinical review before any money changes hands.

## The evidence behind what TrueMe prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How TrueMe compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Piper | Buyers who want the compounding pharmacy named before they hand over a card |  |
| FMmeds | Buyers who want one all-in figure and the compounding pharmacy named beside it |  |
| Cielo | Buyers who want the commitment behind a headline rate spelled out in the asterisk under it |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [JustAnswer Weight Loss](https://thisglp.com/reviews/justanswer-weight-loss) [Jyra Health](https://thisglp.com/reviews/jyra-health) [KERNX Health](https://thisglp.com/reviews/kernx-health) [Kin Meds](https://thisglp.com/reviews/kin-meds) [Kina](https://thisglp.com/reviews/kina) [Knownwell](https://thisglp.com/reviews/knownwell)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Which states does TrueMe serve?

Six: Arizona, Texas, Pennsylvania, Colorado, Missouri and Wisconsin. The product pages list them by name and the home page by abbreviation.

Is there a medical review before payment?

No. The semaglutide page states no intake form is required before you pay, with a full refund promised if a provider does not approve.

Does the price rise with the dose?

No. TrueMe advertises the same price at any dose, though it publishes no milligram figure to show what that ladder covers.

Is TrueMe legit?

TrueMe is a GLP-1 telehealth sellers service. Its stated availability: 6 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.

Is TrueMe expensive compared with other GLP-1 telehealth sellers?

TrueMe publishes a starting figure of $151/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts TrueMe below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
